Abstract:Gastric cancer (GC) is the most common
some degree of persistent inflammation in the mammalian stomach. Gastritis is found in virtually all infected humans, although majority has no symptoms; only one in 10 develop ulcer disease. Gastric adenocarcinoma is 3 to 12 times more likely to develop in individuals infected with H.pylori [23] .H.pylori is more likely to associated with the early or initial states of primary gastric lymphoma than advanced tumors;H.pylori can disappear during progression of gastric lymphoma [24] .Eradication of H.pylori is associated with significant reduction in duodenal ulcer recurrence, and is also useful in differentiating between H.pylori gastritis and gastric MALT, lymphoma(mucosa-associated lymphoid tissue) [25, 26] .In H.pylori infected patients who develop gastric cancer, serum IgG against CagA is 94% sensitive and p3% specific, indicating that detection of antibodies to CagA is useful marker for diagnosis of duodenal and gastric cancer [27] .
H.pylori is an essential risk factor in 60-80% of gastric cancers, but only 2% of people with Helicobacter pylori infections develop stomach cancer [28] .The mechanism by which H.pylori induces stomach cancer potentially involves chronic inflammation, or the action of H.pylorivirulence factors such as CagA [29] .Other studies advocate that H.pylori infection is widely regarded as the most important risk factor in the development of gastric cancer(GC) [30] ,with 0.5% to 2.% developing gastric adenocarcinoma [31] .A metaanalysis of 34 cohort and case-control studied patients found that H.pylori carried a relative risk of GC of 3.02(95%CI:1.92-4.74) in high risk settings(china,Japan and Korea)and 2.56(95%CI:1.99-3.39) in low risk settings(Western Europe, Australia, and the United States [32] .Epidemiological data indicates that GC occurs more frequently in populations with higher rates of H.pyloriinfection, and the World Health Organization has classified this bacterium as a Class 1 carcinogen for GC [28] .H.pylori infection was important in the process of tissue remodeling, angiogenesis, tumor invasion and metastasis [33] and induces a number of genes in the host cells that are potential determinants of inflammation, angiogenesis, and metastasis including interlukin-8(IL-8)gene expression [29] .However, it remains unclear howH.pylori infection activates specific transcription factors and induces gene expression [34] .. Yamada et al. indicated that H.pylori in in Thai GC patients was reported by combined histopathology and H.pylori IgG antibody test with 77.1% and 97.4% of sensitivity and specificity, respectively [35] .Moreover,IL-8mRNA expression is one of the factors that were possible influences which affect GC [36] . Yamada et al. reported that GCs were detected in more than 80% of Thai patients with high levels of IL-8 mRNA expression, whileH.pylori infection and IL-8 mRNA expression were relative risks for Thai GC,therefore IL-8 mRNA expression may be useful diagnostic and prognostic risk marker for GC [25] .Similarly Marci et al. indicated that the level of serum IL-8 mRNA expression may act as marker of GC [37] .The high expression of IL-8 mRNA expression was directly demonstrated with a poor prognostic histologic type in GC [35] .It was estimated that Epstein-Barr virus is responsible for 84,000 cases per year [38] .Other factors associated with increased risk are AIDS [28] .
Smoking and Alcohol: Smoking increases the risk of developing gastric cancer significantly, from 40% increased risk for current smokers to 82% increased risk for heavy smokers. Gastric cancers due to smoking mostly occur in the upper part of the stomach near the esophagus [39] .Some studies show risk with alcohol consumption as well [28] .Consumption of alcohol and smoking are risk factors. Chronic alcohol disturbs gastric mucosal barrier by inhibiting COX 1 receptor enzymes which reduce the production of cytoprotectiveprostaglandin.Cigarette smoking causes reduction of circulating epidermal growth factor and increase free radical production in gastric mucosa [40, 41] .Researchers in Denmark in a series of 2416 subjects found that tobacco smoking and H.pylori infection are the main risk factors for peptic ulcer disease(PUD) in Danish adults [42] .Studies have found that alcohol consumption increases risk when associated with H.pylori infection [43] .Satarasinghe and colleagues in a series of 1500 patients found alcohol was a contributory factor in one third of gastrointestinal bleeding(GIB) patients [44] .
Diet and gastric cancer: Dietary factors are not proven causes but some foods including smoked foods [45, 46] ,salt and salt-rich foods, red meat, processed meat, pickled vegetables [28, 47] ,and bracken are associated with a higher risk of stomach cancer. Nitrates and nitrites in cured meats can be converted by certain bacteria, includingH.pylori,into compounds that have been found to cause stomach cancer in animals [47] .
Fresh fruits and vegetables intake, citrus fruit intake, and antioxidant intake are associated with lower risk of stomach cancer [28] .A Mediterranean diet is associated with lower rates of stomach cancer [48] .Buckland and associated in a series of 485,044 subjects (144,577 men) aged 35-70 year from 10 European countries, concluded that greater adherence to an Mediterranean diet is associated with a significant reduction in the risk of incident gastric cancer [48] .Regular aspirin use is also associated with lower risk of gastric cancer [28] .Intake of total fat is positively associated with gastric cancer risk, and specific subtypes of fats account for different effects [49] .
Obesity is a physical risk factor that has been found to increase the risk of gastric adenocarcinoma by contributing to the development of gastroesophageal reflux disease (GERD) [50] .The exact mechanism by which obesity causes GERD is not completely known. Studies hypothesize that increased dietary fat leading to increased pressure on the stomach and the lower esophageal sphincter, due to access adipose tissue, could play a role,yet no statistically significant data has been collected [51] .However, the risk of gastric cardia adenocarcinoma, with GERD present has been found to increases more than 2 times for an obese person [50] .There is a correlation between iodine deficiency and gastric cancer [52] .
Nagel and associates in a series of 520,000 participants, concluded that higher socioeconomic position was associated with reduced risk of gastric adenocarcinoma [53] .Higher HDI( highest human development index)values, coupled with higher prevalence of male obesity and a higher per capita consumption of alcohol, tobacco, fruits vegetables and meat are associated with a higher incidence of gastric cancer based on an analysis of populational global data [54] .
Role of genetics and family history:About 10% of cases run in families and between 1% and 3% of cases are due to genetic syndromes inherited from person's parents such as hereditary diffuse gastric cancer [14] .A genetic risk factor for gastric cancer is a genetic defect of the CDHI gene known as hereditary diffuse gastric cancer(HDGC).The CDHI gene, which codes for E-cadherin,lies on the 16 th chromosome [55] ..When the gene experiences a particular mutation,gastric cancer develops through a mechanism that is not fully understood [55] .The mutation is considered autosomal dominant meaning that half of a carrier's children will likely experience the same mutation [55] .Diagnosis of hereditary diffuse gastric cancer usually takes place when at least two cases involving a family member, such as parent or grandparent, anddiagnosed, with at least one diagnosed before the age of 50 [55] .The diagnosis can also be made if there are at least three cases in the family, in which case age is not considered [55] .International Cancer Genome Constorium is leading efforts to identify genomic changes involved in stomach cancer [56] .A very small percentage of diffuse-type cancers arise from an inherited abnormal CDHI gene.Genetic testing and treatment options are available for families at risk [57] .
Miscellaneous risk factors include diabetes,perniciousanemia,chronic atrophic gastritis [58] [59] [60] ,Menetrier's disease(hyperplastic,hypersecretorygastropathy),and intestinal metaplasia [61, 62] .
III. Clinical Manifestations
Stomach cancer is often either asymptomatic (producing no noticeable symptoms) or it may cause only nonspecific symptoms (symptoms that specific to stomach cancer and to other related or unrelated disorders).By the symptoms occur, the cancer has often reached and advanced stage and may have metastasized (spread to other, perhaps distant, part of the body),which is one of the reasons for its relatively poor prognosis [63] .Early symptoms of gastric cancer includes: [64] . a).Early cancers may be associated with indigestion or burning sensation (heartburn).However, less than 1 in 50 people referred for endoscopy due to indigestion has cancer. b).Abdominal discomfort and loss of appetite, especially for meat may occur. c).Gastric cancer that have enlarged and invaded normal tissue can cause weakness, fatigue, bloating of stomach after meals, abdominal pain in the upper abdomen, nausea and occasional vomiting, diarrhea or constipation. d).Further enlargement may cause weight loss or bleeding with vomiting blood or having blood in the stool. The latter apparent as black discoloration (melena) and sometimes leading to anemia. Dysphagia suggests a tumor in the cardia or extension of the gastric tumor into the esophagus. e).These can be symptoms of other problems such as a stomach virus,gastric ulcer, or tropical sprue.
IV. Diagnosis
Patient's history and gastroscopic examination is the diagnostic method [59] .Upper GI series (barium roentgenogram),and computed tomography or CT scanning of the abdomen may revel gastric cancer [65] .In 2013,Chinese and Israeli scientists reported a successful pilot study of a breathalyzer-style breath test indented to diagnose stomach cancer by analyzing exhaled chemicals without the need for an intrusive endoscopy [66] .A biopsy with subsequent histological analysis, is the only sure way to confirm the presence of cancer cells [59] .Other gastroscopic modalities such as optical coherence tomography are being tested investigationally for similar applications [67] .A number of cutaneous conditions are associated with gastric cancer include tripe palms, a darkening hyperplasia of the skin of palms [68] .Blood tests for tumor markers, such as CEA(carcinoembryonic antigen) and CA( carbohydrate antigen) may be ordered, as their levels correlate to extent of metastasis especially the liver, and the cure rate [69] . Gastric cancer staging: The clinical staging of gastric cancer includes: [70, 71] . Stage 111.Pnetration to the third layer and more distant lymph nodes, or penetration to the fouth layer or more distant lymph nodes. Treated as for Stage 11; a cure is still possible in some cases.
Stage IV.Cancer has spread to nearby tissues and more distant lymph nodes or has metastastasized to other organs. A cure is rarely possible at this stage.The TNM (tumor,node,and metastasis) system is also used [72] .In a Thai study ,tissue samples were taken by endoscopy with tissue IL-8mRNA expression conducted by real time relative quantitation polymerase chain reaction [73] .
V. Management
Cancer of stomach is difficult to cure unless it is found at an early stage. The disease is usually advanced when diagnosis is made [74] .Treatment for gastric cancer may include surgery, chemotherapy, and / or radiation therapy [75, 76] .New treatment approaches such as biological therapy and improved ways of using current methods are being studied in clinical trials [77] .
Surgery: Surgery remains the only curative therapy for stomach cancer [15] .0f different surgical techniques, endoscopic mucosal resection(EMR) is a treatment for early cancer(tumor only involves the mucosa) that was pioneered in Japan and is available in the United States at some centers [15] .In this procedure, the tumor, together with the inner lining of stomach(mucosa),is removed from the wall of the stomach using an electrical wire loop through the endoscope. The advantage is that it is a smaller operation than removing the stomach [15] .Endoscopic submucosal dissection(ESD) is a similar technique pioneered in Japan used to resect a large area of mucosa in one piece [15] .If the pathologic examination of resected specimen shows incomplete resection or deep invasion by tumor, the patient would need a formal stomach resection [15] .A 2016 Cochrane review found low quality evidence of no difference in short-term mortality between laparoscopic and open gastrectomy(removal of stomach),and that benefits or harms of laparoscopic gastrectomy cannot be ruled out [78] .Those with metastatic disease at the time of presentation may receive palliative surgery and while it remains controversial, due to the possibility of complications from surgery itself and the fact that it may delay chemotherapy the data so far is mostly positive, with improved survival rates being seen in those treated with this approach [16, 79] .
Chemotherapy, Targeted and Radiotherapy:The use of chemotherapy to treat stomach cancer has no firmly established standard care.Unfortunately, stomach cancer has not been particularly sensitive to these drugs,and chemotherapy, if used, has usually served to palliatively reduce the size of tumor, relieve symptoms of the disease and increase survival time.Some drugs used in stomach cancer treatment have included 5-FU(fluorouracil) or its analog capecitabine,BCNU(Carmustine),methyl-CCNU(semustine) and doxorubicin (Adriamycin),as well as mitomycin C, and more recently cisplatin and taxotere, often using drugs in various combinations. The Relative benefits of these drugs, alone and in combination, are unclear [80] .Clinical researchers have explored the benefits of giving chemotherapy before surgery to shrink the tumor,or as adjuvant therapy after surgery to destroy remaining cancer cells [15] .
Recently, treatment with human epidermal growth factor receptor 2(HER2) inhibitor, trastuzumab,has been demonstrated to increase overall survival in inoperable locally advanced or metastatic gastric carcinoma over-expressing the HER2/neu gene [15] .In particular,HER2 is overexpressed in 13-22% of patients with gastric cancer [77, 81] .0f note,HER2 overexpression in gastric neoplasia is heterogeneous and comprises a minority of tumor cells (less than 10% of gastric cancers overexpress HER2 in more than 5% of tumor cells). Hence, this heterogeneous expression should be taken into account for HER2 testing, particularly in small samples such as biopsies, requiring the evaluation of more than one biopsy sample [81] .Radiotherapy may be used to treat stomach cancer, often as an adjuvant to chemotherapy and/or surgery [15] .
VI. Prognosis and Prevention
The prognosis of gastric cancer is generally poor, due to the fact the tumor has often metastasized by the time of discovery and the fact that most people with the condition are elderly (median age is between 70 and 75 years) at presentation [82] .The five years survival rate for gastric cancer is reported to be less than 10 percent [15] . Prevention:Getting rid of H.pylori in those who are infected decreases the risk of gastric cancer,at least in those who are Asian [83] .A 2014 meta-analysis of observational studies found that a diet high in fruits, mushrooms, garlic, soybeans, and green onions was associated with a lower risk of stomach cancer in Korean population [84] .Low doses of vitamins, especially from a healthy diet, decreases the risk of stomach cancer [85] .A previous review of antioxidant supplementation did not find supporting evidence and possibly worse outcomes [86] .
